Shree Pacetronix Limited reported a consolidated net profit of ₹314.39 lakh for the financial year ended March 31, 2026, a significant increase from ₹74.99 lakh in the previous year. Revenue from operations for the year stood at ₹2176.01 lakh, compared to ₹1680.32 lakh in FY25. The Board of Directors approved the audited standalone and consolidated financial results during a meeting held on May 25, 2026.

The standalone net profit for FY26 was ₹301.74 lakh, while profit for the quarter ended March 31, 2026, was ₹97.05 lakh. Earnings per share (EPS) on a consolidated basis for the year increased to ₹8.66 from ₹2.08 in the prior year. The company’s sole business segment is "Life Saving Devices".

Auditor Appointments and Governance

Based on the Audit Committee's recommendation, the Board appointed M/s Apeksha Medatwal & Associates as the Internal Auditor for FY27, replacing M/s Shreyash Sethiya & Associates. The Board also approved the appointment of M/s Agarwal Patel & Sinhal as Statutory Auditors for a period of five years, commencing from the conclusion of the 38th Annual General Meeting until the conclusion of the 43rd Annual General Meeting, subject to shareholder approval.

The Board recommended specific Material Related Party Transactions (RPTs) for shareholder approval. The meeting, which commenced at 3:00 P.M. and concluded at 7:30 P.M., also covered other operational, financial, and administrative matters.

Financial Highlights

The following table summarizes the key financial metrics for the standalone and consolidated entity for the year ended March 31, 2026:

The statutory auditor, M/s S. R. Naredi & Co., issued an unmodified opinion on the standalone and consolidated financial results. The company also declared that the statutory auditor did not express any modified opinion or audit qualification in the audit report accompanying the annual audited financial statements.

Shree Pacetronix Limited has notified the BSE of its upcoming board meeting, in compliance with Regulation 29(1) and (2) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The meeting, designated as the 01st/2026-2027 Board Meeting, is scheduled for Monday, 25th May, 2026, at 03:00 PM, at the company's registered office located at Plot No. 15, Sector-II, Industrial Area, Pithampur, District Dhar, Madhya Pradesh – 454775.

Key Agenda Items

The board will convene to transact several significant businesses during the meeting. The following matters have been formally listed on the agenda:

Trading Window Closure

In accordance with the SEBI (Prohibition of Insider Trading) Regulations, 2015, and the company's internal code of conduct for regulating, monitoring, and reporting of trading by insiders, the trading window for dealing in the company's securities has been closed. The closure applies to Designated Persons, including:

• Directors
• Promoters
• Key Managerial Personnel (KMPs)
• Designated Employees and Connected Persons
• Immediate relatives of the above
• Material Subsidiary of the Company

The trading window closure commenced from 1st April, 2026, and will remain in effect until 48 hours after the announcement and declaration of the standalone and consolidated audited financial results for the quarter and financial year ended March 31, 2026. This closure was originally disclosed to the stock exchange vide the trading window closure disclosure dated 26th March, 2026.

Company Background

Shree Pacetronix Limited, incorporated under CIN No. L33112MP1988PLC004317, is a Madhya Pradesh-based company with over 33 years of operations in cardiac pacing technology. The intimation was signed by Rupali Ahire, Company Secretary, on 16th May, 2026.